T1/T2-weighted ratio: A feasible MRI biomarker in multiple sclerosis
- PMID: 38389172
- DOI: 10.1177/13524585241233448
T1/T2-weighted ratio: A feasible MRI biomarker in multiple sclerosis
Abstract
T1/T2-weighted ratio is a novel magnetic resonance imaging (MRI) biomarker based on conventional sequences, related to microstructural integrity and with increasing use in multiple sclerosis (MS) research. Different from other advanced MRI techniques, this method has the advantage of being based on routinely acquired MRI sequences, a feature that enables analysis of retrospective cohorts with considerable clinical value. This article provides an overview of this method, describing the previous cross-sectional and longitudinal findings in the main MS clinical phenotypes and in different brain tissues: focal white matter (WM) lesions, normal-appearing white matter (NAWM), cortical gray matter (GM), and deep normal-appearing gray matter (NAGM). We also discuss the clinical associations, possible reasons for conflicting results, correlations with other MRI-based measures, and histopathological associations. We highlight the limitations of the biomarker itself and the methodology of each study. Finally, we update the reader on its potential use as an imaging biomarker in research.
Keywords: Biomarker; T1/T2-weighted ratio; magnetic resonance imaging; multiple sclerosis.
Conflict of interest statement
Declaration of Conflicting InterestsThe author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: M.B. has received a speaker honorarium and/or travel expenses for scientific meetings from Biogen, Horizon, Merck, Novartis, and Roche and received a grant as ECTRIMS Clinical Training fellow. J.S.-G. has engaged in consulting and/or participating as speaker/chair in events organized by Merck, Bayer, Celgene, Sanofi, and Biogen and is director of Revista de Neurología and editor for controversies of the Multiple Sclerosis Journal. C.d.M. has received a grant from MSIF-ECTRIMS, speaker honoraria from Roche, Guerbet, and Biogen and is associate editor of
Similar articles
-
T1/T2-weighted ratio in multiple sclerosis: A longitudinal study with clinical associations.Neuroimage Clin. 2022;34:102967. doi: 10.1016/j.nicl.2022.102967. Epub 2022 Feb 16. Neuroimage Clin. 2022. PMID: 35202997 Free PMC article.
-
NODDI, diffusion tensor microstructural abnormalities and atrophy of brain white matter and gray matter contribute to cognitive impairment in multiple sclerosis.J Neurol. 2023 Feb;270(2):810-823. doi: 10.1007/s00415-022-11415-1. Epub 2022 Oct 6. J Neurol. 2023. PMID: 36201016
-
Deep gray matter changes in relapsing-remitting multiple sclerosis detected by multi-parametric, high-resolution magnetic resonance imaging (MRI).Eur Radiol. 2021 Feb;31(2):706-715. doi: 10.1007/s00330-020-07199-5. Epub 2020 Aug 26. Eur Radiol. 2021. PMID: 32851443
-
MRI measures of neurodegeneration in multiple sclerosis: implications for disability, disease monitoring, and treatment.J Neurol. 2015 Jan;262(1):1-6. doi: 10.1007/s00415-014-7340-9. Epub 2014 Apr 11. J Neurol. 2015. PMID: 24723117 Review.
-
T1- and T2-based MRI measures of diffuse gray matter and white matter damage in patients with multiple sclerosis.J Neuroimaging. 2007 Apr;17 Suppl 1:16S-21S. doi: 10.1111/j.1552-6569.2007.00131.x. J Neuroimaging. 2007. PMID: 17425729 Review.
Cited by
-
Complementary MR measures of white matter and their relation to cardiovascular health and cognition.Sci Rep. 2025 Aug 7;15(1):28890. doi: 10.1038/s41598-025-13610-2. Sci Rep. 2025. PMID: 40775500 Free PMC article.
-
The temporal dynamics and clinical relevance of choroid plexus measures in multiple sclerosis.Brain Commun. 2025 Jun 14;7(3):fcaf239. doi: 10.1093/braincomms/fcaf239. eCollection 2025. Brain Commun. 2025. PMID: 40585815 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical